FFO
AUPH icon

Fortitude Family Office’s Aurinia Pharmaceuticals AUPH Stock Holding History

Fortitude Family Office’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02K Buy
+178
New +$2.84K ﹤0.01% 1305

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Fortitude Family Office's AUPH Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 178 shares worth $3.02K. The stake represents ﹤0.01% of the portfolio and ranks #1305 among its holdings.

48 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Fortitude Family Office held 178 shares of Aurinia Pharmaceuticals worth $3.02K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Fortitude Family Office position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1305 holding.
  • 48 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.